Brevan Howard Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-186,984
Closed -$36.6M 2342
2025
Q3
$36.6M Buy
186,984
+112,518
+151% +$18.5M 0.16% 49
2025
Q2
$6.73M Buy
+74,466
New +$5.88M 0.04% 266
2024
Q2
Sell
-5,025
Closed -$373K 1447
2024
Q1
$373K Buy
+5,025
New +$372K ﹤0.01% 569

Other funds holding ALAB

Brevan Howard Capital Management's ALAB Position: Q4 2025 in Review

Brevan Howard Capital Management sold out of Astera Labs (ALAB) in Q4 2025, closing a stake of 186,984 shares — an estimated $36.6M sold.

Brevan Howard Capital Management first reported a position in ALAB in Q1 2024 and held it in 3 quarters. The position peaked at $36.6M in Q3 2025. 700 funds tracked by Wall St. Rank hold ALAB as of Q4 2025.

  • Brevan Howard Capital Management reported no remaining Astera Labs position as of Q4 2025 after selling out during the quarter.
  • Brevan Howard Capital Management sold 186,984 Astera Labs shares in Q4 2025, an estimated $36.6M.
  • Brevan Howard Capital Management first reported a position in Astera Labs in Q1 2024 and held it in 3 quarters.
  • Brevan Howard Capital Management's Astera Labs position peaked at $36.6M in Q3 2025.
  • 700 funds tracked by Wall St. Rank held Astera Labs as of Q4 2025.

Based on Brevan Howard Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.